Clarivate introduces epidemiology intelligence™ for precision patient population analysis

Empowering  biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis london , may 7, 2024 /prnewswire/ -- clarivate plc (nyse: clvt), a leading global provider of transformative intelligence, today announced the launch of epidemiology intelligence™. the new solution combines rich insights from epidemiology, incidence and prevalence database solutions.
CLVT Ratings Summary
CLVT Quant Ranking